Interview with Louis Chiang, President, Giddi Pharma Co. Ltd.
Giddi Pharma was founded in 1995. What was the vision behind the creation of the company? What founding principles did you have when you founded Giddi? When I founded this…
Address: Avenue Provinciale, 30
1340 Louvain-la-Neuve
Belgium
Tel: +32 (0)10 61 44 44
Web: http://www.iddi.com/
IDDI’s business is that of a eClinical and Biostatistical services provider for clinical trials since 1991. IDDI’s mission is to optimize the clinical development of drugs, biologics and devices, using a unique combination of advanced biostatistics and innovative data management technology.
Services:
Innovative trial design
Biostatistics: expert statistical analyses, validation of biomarkers, support to IDMC
Cost effective Data management and Electronic Data Capture
Professional Medical writing
eClinical Suite
IWRS / IVRS : ID-net™, a centralized randomization system integrated with EDC.
ID-supply™ , a drug inventory and treatment allocation system.
ID-code™, a coding of medical terms system based onMedDRA® and WHO-DRUG dictionaries.TrialControl™, a secure eRoom portal to access to key trial data and documents.
Giddi Pharma was founded in 1995. What was the vision behind the creation of the company? What founding principles did you have when you founded Giddi? When I founded this…
Glenn Vaughan of the British Chamber of Commerce | EU & Belgium discusses the importance of the Belgium-UK relationship, the role of healthcare and the life sciences within that, and…
Romuald Gaudefroy, managing director of CAF-DCF, the Belgian subsidiary of the LFB Group, introduces the company which was integrated into LFB in 2016. Gaudefroy goes on to offer insights on…
Miguel Forte, CEO of Bone Therapeutics, walks through his journey leading the promising Belgian biotech company. He also shares with his view of the Belgian healthcare system and what makes…
Brigitte Nolet, country manager of Roche for Belgium and Luxembourg, speaks about her transition to the Belgian market and her priorities for leading the affiliate. Nolet goes on the elaborate…
Jean Nève and Fabrice Peters, president and general coordinator of the Belgian Superior Health Council (SHC), introduce the organization, elaborate on its role in helping guide the country’s healthcare policy,…
Bertrand Duquesne, managing director of Boiron Belgium, elaborates on the challenges being faced by homeopathy manufacturers in western Europe and explains how the company and its peers are create dialogue…
Vincent Verschraegen, country manager of Mylan Belgium and Luxembourg, speaks about his onboarding in the company and what attracted him to join the organization. Verschraegen also discusses Mylan’s evolution from…
PDC*Line Pharma’s Eric Halioua introduces the Belgian immuno-oncology biotech, its clinical-stage assets, the impact of the firm’s collaboration with Korean LG Chem, and future internationalisation strategies. As a multicultural…
Miranda Heining, general manager of Fresenius Kabi for Belgium and the Netherlands, speaks about the career path that led her to join the pharma industry and lead the affiliate, her…
Christos Andriopoulos, managing director of Merck, speaks about his experience transitioning from global operations to leading a country subsidiary. Andriopoulos goes on to explain the company’s unique positioning as an…
Fréderic Covemaeker, general manager of Nordic Pharma Belgium, introduces the Belgian affiliate which he established himself in 2008 and elaborates on the next stage of development for operations as Nordic…
Despite a population size of only 11.4 million (ninth in Europe), Belgium is the continent’s fifth biggest spender on R&D, behind only Germany, Switzerland, the UK, and France according to…
See our Cookie Privacy Policy Here
